FIELD: medicine.
SUBSTANCE: group of inventions concerns medicine, namely to the agents raising action of acoustic energy in a target place during therapy by high-intensive focused ultrasound (HIFU). Application of biocompatible firm substance with nanosized particles, intended for HIFU-therapy, consists in reception of the strengthening agent containing a discrete phase, consisting of biocompatible firm substance with nanosized particles, bagged inside the membrane-creating material; and the continuous phase consisting of water medium, thus a discrete phase is homogeneously dispersed in a continuous phase. The strengthening agent intended for HIFU-therapy, contains a biocompatible firm substance with nanosized particles, the discrete phase homogeneously dispersed in a continuous phase consists of the specified discrete and continuous phases, thus. The way of augmentation of action of acoustic energy in a target place during HIFU-therapy consists in intravenous introduction of the specified strengthening agent in an effective dose by means of continuous and fast intravenous installation or bolus injection to the patient 0-168 hours prior to HIFU-therapy application.
EFFECT: rising of efficiency of HIFU-therapy of deeply located and big tumours at certain acoustic power without damage of normal tissues along an acoustic way.
21 cl, 6 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT STRENGTHENING EFFECT OF PROCESSING BY FOCUSED ULTRASOUND OF HIGH INTENSITY, AND WAY OF SCREENING OF GIVEN AGENT | 2005 |
|
RU2363494C2 |
DISPERSE ACTIVATOR FOR HIGH-INTENSITY FOCUSED ULTRASONIC THERAPY AND ITS APPLICATION | 2005 |
|
RU2360700C2 |
FLUOCARBON EMULSION ACTIVATOR FOR HIGHLY INTENSIVE FOCUSED ULTRASOUND THERAPY AND ITS APPLICATION | 2005 |
|
RU2388492C2 |
THERAPEUTIC BIOPREPARATION FOR TREATING HEPATOCELLULAR CARCINOMA | 2014 |
|
RU2739218C2 |
ULTRASONIC THERAPEUTIC DEVICE | 2005 |
|
RU2358780C2 |
EMBALOGENIC MATRIX DECOMPOSITION METHOD IN EXPERIMENT | 2020 |
|
RU2739669C1 |
METHOD AND DEVICE FOR FOCUSED ULTRASONIC THERAPY OF HIGH INTENSITY | 2005 |
|
RU2359721C2 |
THERAPEUTIC SYSTEM FOR ENERGY RELEASE | 2009 |
|
RU2518524C2 |
APPLICATION OF MITOXANTHONE HYDROCHLORIDE LIPOSOM FOR THE TREATMENT OF BREAST CANCER | 2021 |
|
RU2806277C1 |
ANGIOPOIETIC ANGIOPOIETIN-LIKE PROTEIN 4 INHIBITORS, IN COMBINATIONS AND APPLICATION | 2005 |
|
RU2392966C2 |
Authors
Dates
2009-06-27—Published
2005-08-30—Filed